Abstracts - faqs.org

Abstracts

Business

Search abstracts:
Abstracts » Business

Headache no. 157/159

Article Abstract:

Derivative accounting experts worry that the new Financial Accounting Standards 157 and 159 will be another FAS 133, with the inclusion of a counterparty's credit along with the company's credit rating under fair value. Details on the risk of the new FAS to companies using derivatives are discussed.

Author: Rosenberg, Robert
Publisher: CFO Publishing Corp.
Publication Name: Treasury & Risk
Subject: Business
ISSN:
Year: 2007
Product standards, safety, & recalls, Standards, Derivatives (Financial instruments)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Sometimes shortcuts turn out to be tricky

Article Abstract:

The treasury problems faced by United States firms due to financial accounting standard 133 are presented.

Author: Wood, Duncan
Publisher: CFO Publishing Corp.
Publication Name: Treasury & Risk
Subject: Business
ISSN:
Year: 2007

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Hello? Is there anyone home at the Financial Accounting Standards Board?

Article Abstract:

This article discusses about problems related with FAS 133 of Financial Accounting Standards Board.

Publisher: CFO Publishing Corp.
Publication Name: Treasury & Risk
Subject: Business
ISSN:
Year: 2007

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Laws, regulations and rules, Government regulation, Financial Accounting Standards Board, Financial accounting
Similar abstracts:
  • Abstracts: Gaining confidence. Something to shout about...
  • Abstracts: RNAi-mediated pathways in the nucleus. Synthetic shRNAs as potent RNAi triggers. Silencing the sceptics
  • Abstracts: The genome and transcriptomes of the anti-tumor agent Clostridium novyi-NT
  • Abstracts: IPOs: The narrow window closes? Stock options could no longer be the carrot. Amgen's TPO mimic faces stiff competition
  • Abstracts: Track it. 21st century software: a hard choice. Spoiled for choice
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.